Merus Labs International, Inc. (MSLI) Starts Presentation at Rodman & Renshaw Global Investment Conference

Merus Labs International acquires and licenses branded prescription pharmaceutical products throughout the U.S., Canada, and Europe. The specialty pharmaceutical company has products to treat overactive bladder, chronic bronchitis, pneumonia, and more. Its solutions can meet the needs of big wholesalers and distributors, and also work on a smaller scale for physicians, healthcare providers, and especially patients and their caregivers. For more information, please visit the company’s website at www.meruslabs.com.